Back to Search Start Over

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

Details

Language :
English
ISSN :
08876924 and 14765551
Volume :
31
Issue :
6
Database :
Supplemental Index
Journal :
Leukemia
Publication Type :
Periodical
Accession number :
ejs42846524
Full Text :
https://doi.org/10.1038/leu.2017.58